Suppr超能文献

相似文献

1
Immunity and inflammatory signaling in alcoholic liver disease.
Hepatol Int. 2014 Sep;8 Suppl 2(0 2):439-46. doi: 10.1007/s12072-014-9518-8. Epub 2014 Mar 28.
2
Involvement of hepatic innate immunity in alcoholic liver disease.
Immune Netw. 2010 Dec;10(6):181-7. doi: 10.4110/in.2010.10.6.181. Epub 2010 Dec 31.
3
Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.
Front Immunol. 2019 Jun 12;10:1328. doi: 10.3389/fimmu.2019.01328. eCollection 2019.
4
Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
Drug Metab Pharmacokinet. 2011;26(1):30-46. doi: 10.2133/dmpk.dmpk-10-rv-087. Epub 2010 Dec 7.
5
Cytokines in alcoholic liver disease.
Arch Toxicol. 2012 Sep;86(9):1337-48. doi: 10.1007/s00204-012-0814-6. Epub 2012 Feb 25.
6
Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
J Hepatol. 2016 Apr;64(4):872-80. doi: 10.1016/j.jhep.2015.11.037. Epub 2015 Dec 9.
7
Innate immunity and alcoholic liver disease.
Dig Dis. 2012;30 Suppl 1(Suppl 1):55-60. doi: 10.1159/000341126. Epub 2012 Oct 11.
8
The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease.
Curr Pathobiol Rep. 2016 Mar;4(1):27-35. doi: 10.1007/s40139-016-0097-3. Epub 2016 Feb 19.
9
Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research.
Biomedicines. 2020 Mar 18;8(3):63. doi: 10.3390/biomedicines8030063.

引用本文的文献

1
Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease.
Biomedicines. 2024 Dec 31;13(1):74. doi: 10.3390/biomedicines13010074.
2
Immunology and treatments of fatty liver disease.
Arch Toxicol. 2025 Jan;99(1):127-152. doi: 10.1007/s00204-024-03920-1. Epub 2024 Dec 18.
3
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives.
Clin Mol Hepatol. 2024 Oct;30(4):620-648. doi: 10.3350/cmh.2024.0315. Epub 2024 Jul 11.
4
The Effect of Retinol Acetate on Liver Fibrosis Depends on the Temporal Features of the Development of Pathology.
J Clin Exp Hepatol. 2024 May-Jun;14(3):101338. doi: 10.1016/j.jceh.2023.101338. Epub 2023 Dec 21.
5
A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease.
Int J Biol Sci. 2021 Jan 1;17(1):307-327. doi: 10.7150/ijbs.53589. eCollection 2021.
6
Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells.
J Ginseng Res. 2020 Nov;44(6):815-822. doi: 10.1016/j.jgr.2020.03.002. Epub 2020 Apr 10.
9
Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.
Front Immunol. 2019 Jun 12;10:1328. doi: 10.3389/fimmu.2019.01328. eCollection 2019.
10
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain.
Front Pharmacol. 2019 May 31;10:627. doi: 10.3389/fphar.2019.00627. eCollection 2019.

本文引用的文献

1
Recent trends in the epidemiology of alcoholic liver disease.
Clin Liver Dis (Hoboken). 2013 Apr 24;2(2):53-56. doi: 10.1002/cld.168. eCollection 2013 Apr.
2
Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.
J Leukoc Biol. 2013 Dec;94(6):1167-84. doi: 10.1189/jlb.0313153. Epub 2013 Aug 29.
8
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.
J Clin Invest. 2012 Oct;122(10):3476-89. doi: 10.1172/JCI60777. Epub 2012 Sep 4.
10
Chronic alcohol-induced liver disease inhibits dendritic cell function.
Liver Int. 2011 Aug;31(7):950-63. doi: 10.1111/j.1478-3231.2011.02514.x. Epub 2011 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验